{"DataElement":{"publicId":"2783701","version":"1","preferredName":"Gleason Score Tertiary Gleason Score for Prostate Cancer GleasonTertiaryScore","preferredDefinition":"A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. _definition pending_Tertiary pattern","longName":"2782937v1.0:2783590v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2782937","version":"1","preferredName":"Gleason Score Tertiary Gleason Score for Prostate Cancer","preferredDefinition":"A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. _definition pending","longName":"2547908v1.0:2431266v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2547908","version":"1","preferredName":"Gleason Score for Prostate Cancer","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","longName":"C28084","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23681B08-081C-19C0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-11-29","modifiedBy":"SBREXT","dateModified":"2017-08-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431266","version":"1","preferredName":"Tertiary Gleason Score for Prostate Cancer","preferredDefinition":"definition pending","longName":"C48605","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tertiary Gleason Pattern","conceptCode":"C48605","definition":"Prostate carcinoma patterns occupying less than 5% of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCEA00-2431-36A2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5691D3A5-7FED-1EA1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"9/28/10 Released for use in caTissue Suite version 1.1 and/or 1.2 per owners direction.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2783590","version":"1","preferredName":"GleasonTertiaryScore","preferredDefinition":"Tertiary pattern","longName":"2783590v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"java.lang.Integer","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":"Gleason Pattern 3","ValueMeaning":{"publicId":"2925237","version":"1","preferredName":"Gleason Pattern 3","longName":"2925237","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 3","conceptCode":"C28087","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C181-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FDC7D18-C2A9-DC43-E040-BB89AD431DD5","beginDate":null,"endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"},{"value":"4","valueDescription":"Gleason Pattern 4","ValueMeaning":{"publicId":"2925238","version":"1","preferredName":"Gleason Pattern 4","longName":"2925238","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 4","conceptCode":"C28088","definition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1A3-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FDC7D18-C2B2-DC43-E040-BB89AD431DD5","beginDate":null,"endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"},{"value":"5","valueDescription":"Gleason Pattern 5","ValueMeaning":{"publicId":"2925239","version":"1","preferredName":"Gleason Pattern 5","longName":"2925239","preferredDefinition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 5","conceptCode":"C28089","definition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1C5-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FDC7D18-C2BB-DC43-E040-BB89AD431DD5","beginDate":null,"endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2193207","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFA-EFD4-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56936B90-63F6-4C91-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"CHILLIJ","dateModified":"2010-09-28","changeDescription":"9/28/10 Released for use in caTissue Suite version 1.1 and/or 1.2 per owners direction; added ref to PathAnnotation_SCG CSI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2919341","version":"1.1","longName":"caTissue_Suite1_1","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000322","version":"1","longName":"edu.wustl.catissuecore.domain.PathAnnotation_SCG","context":"NCIP"}]},{"publicId":"2919341","version":"1.2","longName":"caTissue_Suite1_2","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000323","version":"1","longName":"edu.wustl.catissuecore.domain.PathAnnotation_SCG","context":"NCIP"}]}],"AlternateNames":[{"name":"GleasonScore:tertiaryPatternScore","type":"UML Class:UML Attr","context":"NCIP"},{"name":"edu.wustl.catissuecore.domain.PathAnnotation_SCG.GleasonScore.tertiaryPatternScore","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Gleason Score Tertiary Gleason Score for Prostate Cancer GleasonTertiaryScore does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Gleason Score Tertiary Gleason Score for Prostate Cancer GleasonTertiaryScore does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56928469-C489-671B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"CHILLIJ","dateModified":"2010-09-28","changeDescription":"9/28/10 Released for use in caTissue Suite version 1.1 and/or 1.2 per owners direction","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}